Previous studies have demonstrated increased contractile responses to thromboxane A2 (TXA2) mimetics in aortas obtained from male rats compared with those obtained from females. This study was designed to determine the effects of testosterone and 17p-estradiol treatment on TXA2 receptors in cultured rat aortic smooth muscle cells (RASMCs). TXA2 receptor affinity and density were determined through equilibrium binding experiments using the TXA2/ prostaglandin H2 mimetic [1S-(1a,2I(5Z),3a(1E,3R*),4ae)]-7-[3-(3-hydroxy-4-(4'-125iodo- Before menopause, there is an increased incidence of acute myocardial infarction.6-8These observations have raised the possibility that androgenic steroids may play a role in the pathogenesis of cardiovascular diseases.
T hromboxane A2 (TXA2) and its immediate precursor prostaglandin H2 (PGH2) are potent vasoconstrictor and proaggregatory substances synthesized in large quantities by platelets. Because of their common pharmacological effects, they are believed to share a common receptor, known as the TXA2/PGH2 receptor.1 TXA2 synthesis is increased in a variety of cardiovascular diseases, and it has been implicated as an important pathophysiological mediator in these diseases. [2] [3] [4] In this regard, the number of TXA2 receptors in human platelets is increased during acute myocardial infarction in patients and returns to normal values during the convalescent period.5
Before menopause, there is an increased incidence of acute myocardial infarction.6-8These observations have raised the possibility that androgenic steroids may play a role in the pathogenesis of cardiovascular diseases.
Piper and Vane9 originally reported that aortas obtained from male rabbits were more sensitive to "rabbit aorta contracting" substance, a mixture of PGH2 and TXA2, than those obtained from females. Penhos et al0 and Myers et al1' reported that there were sex differences in the sensitivity of mice to the lethal effects of arachidonic acid injected intravenously. In this model of thrombosis and pulmonary vasoconstriction, TXA2 synthesis inhibitors and receptor antagonists protect against the lethal effects of arachidonic acid. Male mice were more sensitive than female mice, and administration of testosterone enhanced the sensitivity to the lethal effects of arachidonic acid. Karanian et al12 found that male rat aortas were more sensitive to the TXA2 mimetic U46619 than female aortas and that the maximum response was greater in the males compared with the females. Sintetos et al13 also found that male rabbit aortas were more sensitive to U46619 than female aortas and that treatment of gonadectomized rabbits with testosterone increased this sensitivity. Collectively, these observations support the notion that the sex steroids may influence vascular TXA2 receptors.
We conducted this study to determine the effects of testosterone and 1713-estradiol 1) 
Radioligand Binding Assays
Cells were washed twice with phosphate buffered saline (37°C) containing 10 ,uM indomethacin and were harvested into 30 ml DMEM containing 10% FCS using 3 ml of 0.05% trypsin-EDTA. After centrifugation at lOOg for 5 minutes, cells were washed with 20 ml Hanks' balanced salt solution volume of 400 gl HBSS for 30 minutes at 37°C. The reaction was stopped by adding 4 ml ice-cold buffer, and the mixture was filtered through GF/C glass fiber filters (Whatman Inc., Clifton, N.J.) and washed three times with 4 ml ice-cold buffer within 10 seconds. Nonspecific binding was defined as the amount of bound radioactivity in the presence of L657925 (10 (Figure 3 ). All data are expressed as mean±SEM.
Results

Radioligand Binding Assays
The binding of 1-BOP, a TXA2 mimetic, to RASMCs has been characterized extensively. 22 In the cells treated with or without sex steroid hormones for 24 hours (Figure 1) 
Changes in Formation of Inositol Trisphosphate
Basal levels of 1P3 were 956±95 cpm/mg protein and 982±115 cpm/mg protein in control and testosterone-treated cells, respectively (n =5, NS). The cpm/mg in testosterone-treated cells and was significantly higher than that of controls (142±49 cpm/mg protein; p<0.05, n=5) ( Figure 5 ). This 1P3 response to U46619 was antagonized by L657925 (1 ,lM receptors, U46619 also had no effect on the maximum increase in [Ca21]i elicited by I-BOP. Collectively, these results indicate that testosterone increased the maximum response to TXA2 in cultured RASMCs through an increase in receptor number without changing its affinity. The significance of the small increases in the [Ca21]i and 1P3 formation in the testosterone-treated cells as they relate to the ultimate effect of testosterone to augment responsiveness to TXA29' 2,13 remains uncertain.
Previously, it has been well established that there are sex-related differences in cardiovascular morbidity and mortality.6-8 In men, the incidence of heart attacks is much greater than in women before menopause.6-8 However, after menopause, this difference disappears. The reasons for the differences in cardiovascular morbidity and mortality between men and women remain unknown. However, the gonadal sex steroids have been implicated as etiologic factors. Furthermore, several reports of premature cardiovascular or cerebrovascular accidents in young ath-letes with androgenic steroid abuse28-31 and a hypogonadal patient treated with testosterone26 suggest that androgenic steroids may play an important role in platelet hyperaggregability, vasospasm, and thrombotic cardiovascular diseases.
The relevance of the observations made in this study to the sex differences in cardiovascular diseases and androgen steroid-induced thrombotic cardiovascular diseases remains uncertain. Given the potential involvement of TXA2 in the pathogenesis of these cardiovascular events, alterations in vascular TXA2 receptors induced by androgens could be an important contributing factor. Clearly, these observations merit further investigation.
